Top View
- Via Electronic Submission January 10, 2020 Jeffrey Bailet, MD Committee Chair Physician-Focused Payment Model Technical Advisory
- Dexrazoxane Has No Impact on Sensitivity of Childhood Leukemic Blasts to Daunorubicin J Styczynski1, M Wysocki2, W Balwierz2 and JR Kowalczyk3
- Australian Statistics on Medicines 2009
- WARNER/2014-12-02/Defs' Expert Report/6368
- Ethyol® (Amifostine)
- Folinic Acid Administration Following MTX As Prophylaxis for GVHD in Allogeneic HSCT Centres in Australia and New Zealand
- Mesna) Injection, for Intravenous Use • Hypersensitivity Reactions: Anaphylactic Reactions Have Been Reported
- Effect of Amifostine on Lung Oxidative Stress After Cyclophosphamide Therapy
- Toxicity Prediction Using Multi-Disciplinary Data Integration and Novel Computational Approaches
- Department of Defense Chemical, Biological, Radiological, and Nuclear Defense Program Annual Report to Congress
- Package Leaflet: Information for the User Olmesartan Medoxomil/Hydrochlorothiazide Alembic 20 Mg/25 Mg Film-Coated Tablets Olme
- Radioprotection and Radiomitigation: from the Bench to Clinical Practice
- Amifostine Before Chemotherapy: Improved Tolerance Profile of the Subcutaneous Over the Intravenous Route
- Supportive Care Agents
- Radio-Protective Effect of Hydrogen Rich Water Combined with Amifostine in Mice
- Code Description Max Qty Rate Comments/Notes J0207 Amifostine 500Mg 3 469.48 J0594 Busulfan 1Mg 60 32.49 J0640 Leucovorin Calciu
- N-Acetylcysteine As a Treatment for Sulphur Mustard Poisoning
- Guidelines for ATC Classification and DDD Assignment 2021
- OPTIMIZATION of AMIFOSTINE ADMINISTRATION for RADIOPROTECTION by Zheng Lu a Dissertation Submitted in Partial Fulfillment Of
- Selective Protection Against Melphalan Genotoxicity a Buschini1, E Anceschi1, C Carlo-Stella2, E Regazzi2, V Rizzoli2, P Poli1 and C Rossi1
- Characterization of and Protection from Neurotoxicity Induced by Oxaliplatin, Bortezomib and Epothilone-B
- Radioprotectors
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- DRUG NAME: Mesna
- Guidelines for ATC Classification and DDD Assignment 2013
- Savene, INN-Dexrazoxane
- 2005 to 2006 Drug Reimbursement Comparison a Look at How Hospitals Are Faring Under ASP T by Linda Gledhill, MHA
- Rutin Ameliorates Methotrexate Induced Hepatic Injury in Rats1
- Case Report Use of Amifostine As a Chemoprotectant During High-Dose Chemotherapy in Autologous Peripheral Blood Stem Cell Transplantation
- Ethyol® (Amifostine) for Injection
- Economics of New Oncology Drug Development Joseph A
- Preventing and Managing Toxicities of High-Dose Methotrexate Scott C
- A Randomized Trial of Amifostine in Patients with High-Dose VIC Chemotherapy Plus Autologous Blood Stem Cell Transplanation
- Resolution Ap (2000) 1
- The Therapeutic Potential of Amifostine on Cyclophosphamide-Induced Testicular Dysfunctioninrats:Anexperimentalstudy
- ATC Code Title
- The Effect of Amifostine, in Chemotherapy, Radiotherapy, As Potential Cytoprotectant, and Immunomodulatory, in Cancer and Autoimmunity Treatment and Prevention
- Comparison of Uroprotective Efficacy of Mesna and Amifostine in Cyclophosphamide- Induced Hemorrhagic Cystitis in Rats